Assessment of Clinical Images, Digital Dermoscopy and Confocal Microscopy for Melanoma Screening
This study aims to evaluate the sensitivity and specificity of clinical images, digital dermoscopy, and confocal microscopy in identifying melanoma, helping to improve the accuracy of melanoma screening.
Confocal Microscopy
+ Dermoscopy
+ Imaging Procedure
Melanoma+11
+ Neoplasms
+ Neoplasms by Histologic Type
Screening Study
Summary
Study start date: May 18, 2018
Actual date on which the first participant was enrolled.This study focuses on finding better ways to screen and diagnose melanoma, a type of skin cancer. It aims to evaluate the usefulness of different imaging techniques such as clinical images, digital dermoscopy images, and in-vivo confocal microscopy for teledermatology, a method of remote healthcare. The study involves individuals with suspicious moles. The goal is to improve the current triage system by incorporating these imaging technologies, which could potentially enhance patient care and address the challenges of melanoma detection. Participants in this study will have their suspicious moles imaged using a smartphone application, digital dermoscopy, and confocal microscopy. After the imaging, they will receive a local anesthetic called lidocaine and undergo a shave or punch biopsy of the suspected melanomas. The results of these imaging techniques will be compared to the biopsy results to determine their accuracy. Participants will be followed up within a week after the study intervention. The study measures the sensitivity and specificity of these imaging modalities, which means how well they can correctly identify melanomas and non-melanomas. The collected data will be analyzed to generate hypotheses for future studies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Screening Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location